I have been providing the cardiology consultative services at Roswell Park for more than 20 years. About 10 years ago Cardio-Oncology became a recognized subsepecialty. Since that time, I have become more involved in some of the research projects at Roswell Park that involve monitoring and follow up of the cardiovascular system in patients undergoing cancer treatments of many different kinds.
- Pokuri VK, ... Spangenthal,E, ....Geore S., Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer; Emerging Treatment Paradigms. J Natl Compr Canc Netw. 2015; Jul; 13(7):e49-55.
- Jarkowski A, ... Spangenthal, EJ, Wong MK, Heart Failure Caused by Molecularly Targeted Therapies for Cancer. Pharmacotherapy. 2011; Jan;31(1):62-75. Review.
- Paulus A, ... Spangenthal, EJ, ... Clinical Relapse in a Patient with Multiple Myeloma Presenting as and Atrial Plasmacytoma. J Clin Oncol, 2011; Jan 20; 29 (3): e47-9.
- Francis J, ... SpangenthalE, Battiwalla M. Reversible Cardiotoxicity With Tyrosine Kinase Inhibitors. Clin Adv Hematol Oncol. 2010; Feb; 8(2)128-32.
- Pande A, ... Spangnethal E, Javle M. Hypertension secondary to antiangiogenic therapy; experience with bevacizumab. Anticancer Res. 2007 Sep-Oct; 27(5B):3465-70